Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols

Sponsor

National Cancer Institute (NCI) (NIH)

Overall Status

Completed

CT.gov ID

NCT00026689

Collaborator

(none)

903

Enrollment

Location

221.5

Duration (Months)

4.1

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Background:

-This protocol will provide a means for screening potential candidates for NCI Radiation Oncology Branch (ROB) protocols.

Objectives:

-To permit evaluation of patients referred to the NCI Radiation Oncology Branch in order to identify individuals who will be suitable candidates for Radiation Oncology Branch clinical research protocols.

Eligibility:

-Patients suspected of having, or with biopsy proven malignant disease or patients with a benign condition for whom radiotherapy is a potential treatment.

Design:

-This is a screening protocol. No investigational treatments will be administered on this protocol.

Condition or Disease	Intervention/Treatment	Phase
Prostate Brain Breast Lung Endometrial

Detailed Description

Background:

-This protocol will provide a means for screening potential candidates for NCI Radiation Oncology Branch (ROB) protocols.

Objectives:

Eligibility:

-Patients suspected of having, or with biopsy proven malignant disease or patients with a benign condition for whom radiotherapy is a potential treatment.

Design:

-This is a screening protocol. No investigational treatments will be administered on this protocol.

Study Design

Study Type:

Observational

Actual Enrollment :

903 participants

Observational Model:

Case-Only

Time Perspective:

Cross-Sectional

Official Title:

Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols

Study Start Date :

Sep 11, 2000

Study Completion Date :

Feb 25, 2019

Arms and Interventions

Arm	Intervention/Treatment
1/Cohort 1 Patients suspected of having, or with biopsy proven malignant disease or patients with a benign condition for whom radiotherapy is a potential treatment

Outcome Measures

Primary Outcome Measures

To permit evaluation of patients referred to the NCI Radiation Oncology Branch in order to identify individuals who will be suitable candidates for Radiation Oncology Branch clinical research protocols. [Completion of study]
Evaluation of patients referred to the NCI Radiation Oncology Branch in order to identify individuals who will be suitable candidates for Radiation Oncology Branch clinical research protocols.

Eligibility Criteria

Criteria

Ages Eligible for Study:

N/A to 90 Years

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

INCLUSION CRITERIA:

Patients suspected of having, or with biopsy proven malignant disease or patients with a benign condition for whom radiotherapy is a potential treatment.

Patient or guardian is able to provide informed consent.

EXCLUSION CRITERIA:

Candidates who do not meet the inclusion criteria.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	National Institutes of Health Clinical Center, 9000 Rockville Pike	Bethesda	Maryland	United States	20892

Sponsors and Collaborators

National Cancer Institute (NCI)

Investigators

Principal Investigator: Kevin A Camphausen, M.D., National Cancer Institute (NCI)

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

National Cancer Institute (NCI)

ClinicalTrials.gov Identifier:

NCT00026689

Other Study ID Numbers:

000181
00-C-0181
NCT00020280

First Posted:

Nov 15, 2001

Last Update Posted:

Dec 12, 2019

Last Verified:

Feb 25, 2019

Keywords provided by National Cancer Institute (NCI)

Study Results

No Results Posted as of Dec 12, 2019